Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
200-711-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
General Information
Revision date
2018-08-30
Product name
Dacarbazine for Injection, USP
Chemical name
Not determined
Icons in SDS
Company Information
company name
Hospira, A Pfizer Company
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H351, H360D
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
2.1 Classification of the substance or mixture
Germ Cell Mutagenicity: Category 2 Reproductive Toxicity: Category 1B Carcinogenicity: Category 2
Signal word
Danger
Hazard statements
H341 - Suspected of causing genetic defects H351 - Suspected of causing cancer H360D - May damage the unborn child
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
No data available Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
